Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-22,618
Closed -$222K 264
2025
Q2
$222K Sell
22,618
-30,606
-58% -$253K 0.16% 111
2025
Q1
$387K Buy
53,224
+26,382
+98% +$231K 0.32% 70
2024
Q4
$258K Buy
+26,842
New +$221K 0.21% 86

Other funds holding ETNB

Persistent Asset Partners's ETNB Position: Q3 2025 in Review

Persistent Asset Partners sold out of 89bio (ETNB) in Q3 2025, closing a stake of 22,618 shares — an estimated $222K sold.

Persistent Asset Partners first reported a position in ETNB in Q4 2024 and held it in 3 quarters. The position peaked at $387K in Q1 2025. 198 funds tracked by Wall St. Rank hold ETNB as of Q3 2025.

  • Persistent Asset Partners reported no remaining 89bio position as of Q3 2025 after selling out during the quarter.
  • Persistent Asset Partners sold 22,618 89bio shares in Q3 2025, an estimated $222K.
  • Persistent Asset Partners first reported a position in 89bio in Q4 2024 and held it in 3 quarters.
  • Persistent Asset Partners's 89bio position peaked at $387K in Q1 2025.
  • 198 funds tracked by Wall St. Rank held 89bio as of Q3 2025.

Based on Persistent Asset Partners's 13F filing for Q3 2025, filed 10 Nov 2025.